Senescence Life Sciences is at the forefront of brain health. We provide our partners with the most exciting breakthroughs in addressing age, disease and lifestyle-related disruptions in cognitive performance.
From consumer-ready, clinically-tested supplements and combating decision fatigue, to tackling Alzheimer’s – one of the most important health challenges of our time – we are committed to the highest levels of scientific rigour and commercial excellence.
Here are a few billion reasons why brain health is a smart investment:
Global brain health supplement market hit US $3.2 billion in 2016.1
Forecast to reach US $5.8 billion by 2023.1
SLS Nutraceuticals is a B2B market leader in the research, development and sale of innovative nutraceuticals designed to improve brain health and increase cognitive performance.
There are 2.5 billion gamers across the world 2, most of whom likely suffer from decision fatigue.3
There are 1.3 million active duty personal in the US military.4 Decision fatigue affects their ability to make proper decisions while shooting.5
SLS Performance is a pre-clinical biotechnology company focused on the research and development of a new type of nootropic designed to combat decision fatigue in military personnel and elite intellectual athletes.
1 in 3 seniors will die from Alzheimer’s, more than breast and prostate cancer combined.6
Costs of Alzheimer’s Disease are expected to pass $1.1 trillion by 2050. 7
SLS Pharmaceuticals is a pre-clinical pharmaceutical company developing a multi-therapeutic drug targeting lipid dysfunction in Alzheimer’s disease.
With sound business strategy, esteemed medical and business advisers and breakthrough technology, we are positioned to address many greenfield opportunities in brain health.
For information on partnership and investment, please contact [email protected] [email protected]